Siga Technologies, INC.

biodefense countermeasure pharmaceutical company

Based in NY

🤖

AI Overview

With $1.5M in lobbying spend across 22 quarterly filings, Siga Technologies, INC is a significant lobbying presence. Their lobbying covers 3 issue areas. Active from 2020 to 2025.

$1.5M
Total Spend
6
Years Active
1
Firms Hired
1
Lobbyists Deployed
3
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2020$50K
2021$240K
2022$240K
2023$240K
2024$240K
2025$510K

Issues Lobbied

Lobbying Firms

Lobbyists

Government Agencies Targeted

These are the government entities that Siga Technologies, INC. disclosed contacting in their lobbying filings.

HOUSE OF REPRESENTATIVESSENATEExecutive Office of the President (EOP)Defense, Dept of (DOD)Health & Human Services, Dept of (HHS)
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Budget/Appropriations, Defense, Health Issues

Issues related to biodefense countermeasures

H.R. 133, Consolidated Appropriations Act FY2021- Issues related to biodefense countermeasures.

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.